Browse studies

Find your next paid study

4 recruiting studies matching your filters

A Phase 1/2/3, Open-Label, Dose Escalation, Dose Expansion and Randomized, Controlled Study to Evaluate the Safety and Efficacy of ATSN-201 Gene Therapy in Subjects With RS1-Associated X-linked Retinoschisis (LIGHTHOUSE)

This study will evaluate the safety and efficacy of ATSN-201 in subjects ≥ 5 years of age with RS1-associated X-linked retinoschisis (XLRS).

X-linked Retinoschisis

Estimated

~$10 – $8,750

Atsena Therapeutics Inc.NCT05878860

Foundation Fighting Blindness My Retina Tracker Registry

The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative …

Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more

Estimated

~$10 – $750

Foundation Fighting BlindnessNCT02435940

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with …

Retinitis PigmentosaStargardt Macular DystrophyStargardt Disease+3 more

Estimated

~$10 – $1,050

Ray Therapeutics, Inc.NCT07502664

Observational, Non-Interventional Study to Determine the Operational Feasibility and Measurement Properties of Endpoints in Patients with Retinal Degeneration

The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with …

Retinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more

Estimated

~$10 – $1,050

Ray Therapeutics, Inc.NCT06375239